Arunjyoti Bio Ventures Limited Reports Share Acquisition by Chennupati Sarath Kumar
Arunjyoti Bio Ventures Limited reported a share acquisition by Chennupati Sarath Kumar under SEBI disclosure requirements. The non-promoter acquired 54,25,516 equity shares representing 2.91% of the company's total capital through open market transactions between April 13-16, 2026, changing his shareholding position in the BSE-listed company.

*this image is generated using AI for illustrative purposes only.
Arunjyoti bio ventures Limited has filed a disclosure under Regulation 29(2) of SEBI (Substantial Acquisition of Shares and Takeovers) Regulations, 2011, reporting a share acquisition transaction by Chennupati Sarath Kumar. The disclosure, dated April 16, 2026, was submitted to BSE Limited where the company's shares are listed.
Transaction Details
Chennupati Sarath Kumar, who is not part of the promoter or promoter group, acquired shares in the company through open market transactions. The acquisition was executed over a period spanning from April 13, 2026, to April 16, 2026.
| Transaction Parameter: | Details |
|---|---|
| Shares Acquired: | 54,25,516 equity shares |
| Percentage of Total Capital: | 2.91% |
| Transaction Mode: | Open Market |
| Transaction Period: | April 13, 2026 to April 16, 2026 |
| Acquirer Category: | Non-Promoter |
Shareholding Pattern Changes
The transaction resulted in an increase in Chennupati Sarath Kumar's stake in Arunjyoti Bio Ventures Limited. His shareholding position changed following the completion of the acquisition.
| Shareholding Details: | Before Acquisition | After Acquisition | Change |
|---|---|---|---|
| Number of Shares: | 1,41,01,138 | 86,75,622 | +54,25,516 |
| Percentage Holding: | 7.57% | 4.66% | +2.91% |
Company Capital Structure
The company's equity share capital structure remained unchanged following this transaction. Arunjyoti Bio Ventures Limited maintains its existing capital base without any alterations to the total number of shares or their face value.
| Capital Structure: | Details |
|---|---|
| Total Equity Capital: | Rs. 18,63,81,000 |
| Number of Shares: | 18,63,81,000 |
| Face Value per Share: | Re. 1/- |
| Listing Exchange: | BSE Limited |
| Scrip Code: | 530881 |
Regulatory Compliance
The disclosure was made in compliance with SEBI regulations governing substantial acquisition and disposal of shares. The transaction falls under the purview of Regulation 29(2) of SEBI (Substantial Acquisition of Shares and Takeovers) Regulations, 2011, which mandates disclosure when shareholding changes exceed specified thresholds. The filing ensures transparency and keeps investors informed about significant changes in shareholding patterns of listed companies.
Historical Stock Returns for Arunjyothi Bio Ventures
| 1 Day | 5 Days | 1 Month | 6 Months | 1 Year | 5 Years |
|---|---|---|---|---|---|
| +4.97% | -14.27% | 0.0% | -46.22% | -25.74% | +2,747.83% |
What strategic plans might Chennupati Sarath Kumar have for his increased 7.57% stake in Arunjyoti Bio Ventures?
Could this significant acquisition signal potential consolidation or partnership opportunities in the biotechnology sector?
How might this shareholding change impact Arunjyoti Bio Ventures' board composition and corporate governance decisions?
































